Viewing Study NCT06725368


Ignite Creation Date: 2025-12-24 @ 5:54 PM
Ignite Modification Date: 2025-12-24 @ 5:54 PM
Study NCT ID: NCT06725368
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2024-11-28
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: Centre Paul Strauss
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module